Cholinergic pathways modulate experimental dinitrobenzene sulfonic acid colitis in rats

Area of Science:

• Neuroimmunology
• Gastroenterology
• Pharmacology

Background:

• Neuroimmune interactions are increasingly recognized for their role in modulating intestinal immunity.
• Cholinergic pathways, involving the neurotransmitter acetylcholine, are key components of the nervous system's influence on inflammation.

Purpose of the Study:

• To investigate the role of cholinergic pathways in the severity of acute dinitrobenzene sulfonic acid (DNBS)-induced colitis.
• To evaluate the effects of acetylcholinesterase inhibitors on colitis markers in rat models.

Main Methods:

• Acute colitis was induced using intrarectal dinitrobenzene sulfonic acid in Sprague-Dawley rats, Flinder's Sensitive Line rats, and Flinder's Resistant Line rats.
• Acetylcholinesterase inhibitors (physostigmine, neostigmine) were administered to Sprague-Dawley rats prior to DNBS induction.
• Colitis severity was assessed by macroscopic damage score, myeloperoxidase activity, and smooth muscle thickness on day 5.

Main Results:

• DNBS induced significant colonic damage, increased myeloperoxidase activity, and smooth muscle thickness in Sprague-Dawley and Flinder's Resistant Line rats.
• Flinder's Sensitive Line rats showed resistance to DNBS-induced colitis.
• Pretreatment with physostigmine or neostigmine significantly attenuated DNBS-induced colitis markers, with physostigmine showing greater reduction in myeloperoxidase activity.

Conclusions:

• Cholinergic pathways play a significant role in modulating acute colonic inflammation in the DNBS model.
• Central cholinergic pathways appear to exert a greater protective effect against colitis compared to peripheral pathways.
• Further research is needed to elucidate the specific neural sites and neuro-effector mechanisms involved.